Join to View Full Profile
1420 Beverly RoadSte 300McLean, VA 22101
Phone+1 888-896-1400
Dr. Ailani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jessica Ailani is a neurologist in McLean, VA and is affiliated with MedStar Georgetown University Hospital. She received her medical degree from Stony Brook University School of Medicine and has been in practice 16 years. She specializes in headache and is experienced in headache medicine, migraine disorders, and botulinum toxin injections for headache.
Education & Training
NYU Grossman School of MedicineResidency, Neurology, 2005 - 2008
NYU Grossman Long Island School of MedicineInternship, Internal Medicine, 2004 - 2005
Stony Brook University Health Sciences Center School of MedicineClass of 2004
Certifications & Licensure
DC State Medical License 2009 - 2026
VA State Medical License 2010 - 2026
MD State Medical License 2015 - 2024
NY State Medical License 2005 - 2010
PA State Medical License 2008 - 2009
American Board of Psychiatry and Neurology Neurology
UCNSHeadache Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification MEDSEEK Empower, SymphonyCare, LLC, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial.Amaal J Starling, David Kudrow, Neha Kapur, Susanne F Awad, S Wald Grossman
Pain and Therapy. 2026-06-01 - Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-lab...John Rothrock, Umer Najib, Jessica Ailani, Sait Ashina, Jia Bao
Cephalalgia. 2026-04-01 - Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc A...Patricia Pozo-Rosich, Cristina Tassorelli, Line Pickering Boserup, Susanne F Awad, Xin Ying Lee
Neurology and Therapy. 2026-04-01
Authored Content
- AHS 2021: Sex and Gender-Specific Differences in HeadacheJune 2021
Press Mentions
Satsuma Pharmaceuticals and SNBL Announce Publication of Impression of Use and Satisfaction with STS101 (Dihydroergotamine Nasal Powder (Atzumi™)) in HeadacheNovember 5th, 2025- Clinically Speaking: Questions and Answers About Migraine TreatmentsJune 12th, 2025
- Epidural Patching Outcomes and Predictors of Benefit in Patients with Suspected CSF LeakJuly 11th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
